Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein -Positive Advanced Solid Tumours

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is an exploratory clinical study evaluating the safety, tolerability and biodistribution characteristics of 177Lu-FAP-VG11 injection in patients with FAP-positive advanced solid tumours.
Epistemonikos ID: 67d1413323bf00565cadea31a39a8e61e2b460ce
First added on: Sep 09, 2026